Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Two-Part Study to Evaluate the Safety and Efficacy of Image Guided Surgery Using Indocyanine Green for Intramolecular Imaging of Nervous System Tumors Compared to Standard of Care, (TumorGlow)

NCT03262636 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.

NCT NCT03262636
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03262636 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Two-Part Study to Evaluate the Safety and Efficacy of Image Guided Surgery Using Indocyanine Green for Intramolecular Imaging of Nervous System Tumors Compared to Standard of Care, (TumorGlow)
Lead sponsor
University of Pennsylvania
Phase
Phase 1
Overall status
Completed
Start date
June 30, 2015
Completion date
March 10, 2020
Enrollment
363 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

brain tumor, primary, brain tumor, recurrent